Wednesday, September 16, 2026Latest filing Sep 14, 2026

AXON Congressional Stock Trades

Axon Enterprise, Inc. - Common Stock

Last disclosed trade Mar 27

Every disclosed trade in AXON by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Alan Armstrong · Bought $AXON · Mar 27 · $1K–$15K

0.25LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $AXON

Get notified when any member of Congress trades $AXON. Free, no card, no spam.

Follow free →
1
Disclosed trades
1
Buys
0
Sells
1
Members trading

The record on $AXON

Coldpine has parsed 1 disclosed trade in $AXON by 1 member of Congress, drawn from 1 periodic transaction report dated Mar 27, 2026. It came from the Senate, filed by a Republican.

The one trade with a known filing lag was reported 116 days after the trade date, outside the 45-day window the STOCK Act sets: a $AXON purchase by Alan Armstrong dated Mar 27, 2026, disclosed Jul 21, 2026. How late filing is measured across all of Congress is in the late-filers study.

The one trade that lists an account holder was reported under the member directly, not a spouse, dependent child, or joint account.

Members who trade AXON

Recent disclosed trades in AXON

DateMemberTypeAmount
Mar 27Alan Armstrong(OK)buy$1K–$15K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →